Trial Profile
Botulinum neurotoxin type A (Xeomin) as a treatment option for allergic and intrinsic rhinitis [Botulinum Neurotoxin Typ A (Xeomin) als Therapieoption der allergischen und intrinsischen Rhinitis]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Oct 2013
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Allergic rhinitis; Rhinitis
- Focus Therapeutic Use
- 08 Oct 2013 Status changed from recruiting to completed.
- 17 Aug 2012 New trial record